The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO
Küçük Resim Yok
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Future Medicine Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer patients whose gastric primary tumor was resected at time of diagnosis were compared with metastatic gastric cancer patients whose primary tumor was nonresected. Results: The median progression-free survival and OS in operated and nonoperated group were 10 versus 6, 14 versus 9 months, respectively (p < 0.001). In multivariate analysis, gastric resection of primary tumor, Eastern Cooperative Oncology Group performance status, second-line chemotherapy had a significant effect on OS (hazard ratio [HR]: 0.52 [95% CI: 0.38-0.71], HR: 0.57 [95% CI: 0.42-0.78], HR: 1.48 [1.09-2.01]; p <= 0.001, p = 0.001 and p = 0.012, respectively). Conclusion: Subpopulations of patients with metastatic gastric cancer might benefit from surgical removal of primary tumor.
Açıklama
Anahtar Kelimeler
Advanced Gastric Cancer, Gastrectomy, Resection, Survival, Renal-Cell Carcinoma, Palliative Gastrectomy, Cytoreductive Nephrectomy, Plus Fluorouracil, Phase-Iii, Resection, Cisplatin, Surgery, Chemotherapy, Experience
Kaynak
Future Oncology
WoS Q Değeri
Q3
Scopus Q Değeri
Q1
Cilt
12
Sayı
3
